These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8340372)

  • 1. The 28-kDa N-terminal domain of mouse stromelysin-3 has the general properties of a weak metalloproteinase.
    Murphy G; Segain JP; O'Shea M; Cockett M; Ioannou C; Lefebvre O; Chambon P; Basset P
    J Biol Chem; 1993 Jul; 268(21):15435-41. PubMed ID: 8340372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the C-terminal domain in collagenase and stromelysin specificity.
    Murphy G; Allan JA; Willenbrock F; Cockett MI; O'Connell JP; Docherty AJ
    J Biol Chem; 1992 May; 267(14):9612-8. PubMed ID: 1315762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of zinc-binding- and hemopexin domain-encoded sequences in the substrate specificity of collagenase and stromelysin-2 as revealed by chimeric proteins.
    Sanchez-Lopez R; Alexander CM; Behrendtsen O; Breathnach R; Werb Z
    J Biol Chem; 1993 Apr; 268(10):7238-47. PubMed ID: 8463259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the 92-kDa gelatinase by stromelysin and 4-aminophenylmercuric acetate. Differential processing and stabilization of the carboxyl-terminal domain by tissue inhibitor of metalloproteinases (TIMP).
    Shapiro SD; Fliszar CJ; Broekelmann TJ; Mecham RP; Senior RM; Welgus HG
    J Biol Chem; 1995 Mar; 270(11):6351-6. PubMed ID: 7890773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of the C-terminal domain of metalloproteinases to binding by tissue inhibitor of metalloproteinases. C-terminal truncated stromelysin and matrilysin exhibit equally compromised binding affinities as compared to full-length stromelysin.
    Baragi VM; Fliszar CJ; Conroy MC; Ye QZ; Shipley JM; Welgus HG
    J Biol Chem; 1994 Apr; 269(17):12692-7. PubMed ID: 8175679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrolytic inactivation of a breast carcinoma cell-derived serpin by human stromelysin-3.
    Pei D; Majmudar G; Weiss SJ
    J Biol Chem; 1994 Oct; 269(41):25849-55. PubMed ID: 7523394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human fibroblast stromelysin catalytic domain: expression, purification, and characterization of a C-terminally truncated form.
    Marcy AI; Eiberger LL; Harrison R; Chan HK; Hutchinson NI; Hagmann WK; Cameron PM; Boulton DA; Hermes JD
    Biochemistry; 1991 Jul; 30(26):6476-83. PubMed ID: 1647201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the 46-kDa intermediates of matrix metalloproteinase 3 (stromelysin 1) obtained by site-directed mutation of phenylalanine 83.
    Benbow U; Butticè G; Nagase H; Kurkinen M
    J Biol Chem; 1996 May; 271(18):10715-22. PubMed ID: 8631880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different domain interactions are involved in the binding of tissue inhibitors of metalloproteinases to stromelysin-1 and gelatinase A.
    Nguyen Q; Willenbrock F; Cockett MI; O'Shea M; Docherty AJ; Murphy G
    Biochemistry; 1994 Mar; 33(8):2089-95. PubMed ID: 8117665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chondrocyte cultures express matrix metalloproteinase mRNA and immunoreactive protein; stromelysin-1 and 72 kDa gelatinase are localized in extracellular matrix vesicles.
    Schmitz JP; Dean DD; Schwartz Z; Cochran DL; Grant GM; Klebe RJ; Nakaya H; Boyan BD
    J Cell Biochem; 1996 Jun; 61(3):375-91. PubMed ID: 8761942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical characterization of the catalytic domain of human matrix metalloproteinase 19. Evidence for a role as a potent basement membrane degrading enzyme.
    Stracke JO; Hutton M; Stewart M; Pendás AM; Smith B; López-Otin C; Murphy G; Knäuper V
    J Biol Chem; 2000 May; 275(20):14809-16. PubMed ID: 10809722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of latent and high Mr active forms of stromelysin to collagen is mediated by the C-terminal domain.
    Allan JA; Hembry RM; Angal S; Reynolds JJ; Murphy G
    J Cell Sci; 1991 Aug; 99 ( Pt 4)():789-95. PubMed ID: 1770006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification and characterization of a two-chain form of tissue inhibitor of metalloproteinases (TIMP) type 2 and a low molecular weight TIMP-like protein.
    Miyazaki K; Funahashi K; Numata Y; Koshikawa N; Akaogi K; Kikkawa Y; Yasumitsu H; Umeda M
    J Biol Chem; 1993 Jul; 268(19):14387-93. PubMed ID: 8314798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukemic cells (HL-60) produce a novel extracellular matrix-degrading proteinase that is not inhibited by tissue inhibitors of matrix metalloproteinases (TIMPs).
    Dittmann KH; Lottspeich F; Ries C; Petrides PE
    Exp Hematol; 1995 Feb; 23(2):155-60. PubMed ID: 7828672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibodies against human collagenase and stromelysin.
    Su JL; Becherer JD; Edwards C; Bukhart W; McGeehan GM; Champion BR
    Hybridoma; 1995 Aug; 14(4):383-90. PubMed ID: 8522351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of structural determinants controlling human and mouse stromelysin-3 proteolytic activities.
    Noël A; Santavicca M; Stoll I; L'Hoir C; Staub A; Murphy G; Rio MC; Basset P
    J Biol Chem; 1995 Sep; 270(39):22866-72. PubMed ID: 7559421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin.
    Goldberg GI; Strongin A; Collier IE; Genrich LT; Marmer BL
    J Biol Chem; 1992 Mar; 267(7):4583-91. PubMed ID: 1311314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary structure and function of stromelysin/transin in cartilage matrix turnover.
    Wilhelm SM; Wunderlich D; Maniglia CA; Eisen AZ; Goldberg GI
    Matrix Suppl; 1992; 1():37-44. PubMed ID: 1480063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification of recombinant human prostromelysin. Studies on heat activation to give high-Mr and low-Mr active forms, and a comparison of recombinant with natural stromelysin activities.
    Koklitis PA; Murphy G; Sutton C; Angal S
    Biochem J; 1991 May; 276 ( Pt 1)(Pt 1):217-21. PubMed ID: 2039471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties.
    Okada Y; Gonoji Y; Naka K; Tomita K; Nakanishi I; Iwata K; Yamashita K; Hayakawa T
    J Biol Chem; 1992 Oct; 267(30):21712-9. PubMed ID: 1400481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.